Literature DB >> 18809576

Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors.

Bruno K Robbs1, Andre L S Cruz, Miriam B F Werneck, Giuliana P Mognol, João P B Viola.   

Abstract

Nuclear factor of activated T cells (NFAT) was first described as an activation and differentiation transcription factor in lymphocytes. Several in vitro studies suggest that NFAT family members are redundant proteins. However, analysis of mice deficient for NFAT proteins suggested different roles for the NFAT family of transcription factors in the regulation of cell proliferation and apoptosis. NFAT may also regulate several cell cycle and survival factors influencing tumor growth and survival. Here, we demonstrate that two constitutively active forms of NFAT proteins (CA-NFAT1 and CA-NFAT2 short isoform) induce distinct phenotypes in NIH 3T3 cells. Whereas CA-NFAT1 expression induces cell cycle arrest and apoptosis in NIH 3T3 fibroblasts, CA-NFAT2 short isoform leads to increased proliferation capacity and induction of cell transformation. Furthermore, NFAT1-deficient mice showed an increased propensity for chemical carcinogen-induced tumor formation, and CA-NFAT1 expression subverted the transformation of NIH 3T3 cells induced by the H-rasV12 oncogene. The differential roles for NFAT1 are at least partially due to the protein C-terminal domain. These results suggest that the NFAT1 gene acts as a tumor suppressor gene and the NFAT2 short isoform acts gene as an oncogene, supporting different roles for the two transcription factors in tumor development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18809576      PMCID: PMC2593389          DOI: 10.1128/MCB.00256-08

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  45 in total

1.  Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells.

Authors:  S Chuvpilo; M Zimmer; A Kerstan; J Glöckner; A Avots; C Escher; C Fischer; I Inashkina; E Jankevics; F Berberich-Siebelt; E Schmitt; E Serfling
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

2.  Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.

Authors:  S Chuvpilo; A Avots; F Berberich-Siebelt; J Glöckner; C Fischer; A Kerstan; C Escher; I Inashkina; F Hlubek; E Jankevics; T Brabletz; E Serfling
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 3.  Intrinsic tumour suppression.

Authors:  Scott W Lowe; Enrique Cepero; Gerard Evan
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

4.  The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas.

Authors:  Teresa Marafioti; Teresa Marafiot; Michela Pozzobon; Martin-Leo Hansmann; Roland Ventura; Stefano A Pileri; Helen Roberton; Stefan Gesk; Philippe Gaulard; Thomas F E Barth; Ming Q Du; Lorenzo Leoncini; Peter Möller; Yasodha Natkunam; Reiner Siebert; David Y Mason
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998

5.  Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum.

Authors:  J L de la Pompa; L A Timmerman; H Takimoto; H Yoshida; A J Elia; E Samper; J Potter; A Wakeham; L Marengere; B L Langille; G R Crabtree; T W Mak
Journal:  Nature       Date:  1998-03-12       Impact factor: 49.962

6.  The transcription factor NF-ATc is essential for cardiac valve formation.

Authors:  A M Ranger; M J Grusby; M R Hodge; E M Gravallese; F C de la Brousse; T Hoey; C Mickanin; H S Baldwin; L H Glimcher
Journal:  Nature       Date:  1998-03-12       Impact factor: 49.962

Review 7.  NFAT transcription factors: from cell cycle to tumor development.

Authors:  J P B Viola; L D S Carvalho; B P F Fonseca; L K Teixeira
Journal:  Braz J Med Biol Res       Date:  2005-03-08       Impact factor: 2.590

8.  Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.

Authors:  Javier Duque; Manuel Fresno; Miguel A Iñiguez
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

9.  Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development.

Authors:  A M Ranger; M Oukka; J Rengarajan; L H Glimcher
Journal:  Immunity       Date:  1998-11       Impact factor: 31.745

10.  Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.

Authors:  Irina Bonzheim; Eva Geissinger; Sabine Roth; Andreas Zettl; Alexander Marx; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Blood       Date:  2004-08-05       Impact factor: 22.113

View more
  74 in total

Review 1.  Primers on molecular pathways--the NFAT transcription pathway in pancreatic cancer.

Authors:  Alexander König; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Pancreatology       Date:  2010-08-19       Impact factor: 3.996

Review 2.  NFAT, immunity and cancer: a transcription factor comes of age.

Authors:  Martin R Müller; Anjana Rao
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

3.  Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.

Authors:  Akiko Takeda; Nayan J Sarma; Anmaar M Abdul-Nabi; Nabeel R Yaseen
Journal:  J Biol Chem       Date:  2010-03-16       Impact factor: 5.157

4.  NFAT1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.

Authors:  Leonardo K Teixeira; Nina Carrossini; Cristiane Sécca; José E Kroll; Déborah C DaCunha; Douglas V Faget; Lilian D S Carvalho; Sandro J de Souza; João P B Viola
Journal:  Cell Cycle       Date:  2016-07-11       Impact factor: 4.534

5.  β-Secretase 1 and its Naturally Occurring Anti-Sense RNA are Down-Regulated in Gastric Cancer.

Authors:  Farbod Esfandi; Soudeh Ghafouri-Fard; Vahid Kholghi Oskooei; Mohammad Taheri
Journal:  Pathol Oncol Res       Date:  2019-02-25       Impact factor: 3.201

6.  NFAT isoforms control activity-dependent muscle fiber type specification.

Authors:  Elisa Calabria; Stefano Ciciliot; Irene Moretti; Marta Garcia; Anne Picard; Kenneth A Dyar; Giorgia Pallafacchina; Jana Tothova; Stefano Schiaffino; Marta Murgia
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-24       Impact factor: 11.205

7.  Transcriptional regulation of the human telomerase reverse transcriptase: new insights.

Authors:  Amel Chebel; Martine Ffrench
Journal:  Transcription       Date:  2010 Jul-Aug

8.  Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses.

Authors:  Katja Spiess; Suzan Fares; Alexander H Sparre-Ulrich; Ellen Hilgenberg; Michael A Jarvis; Bernhard Ehlers; Mette M Rosenkilde
Journal:  J Virol       Date:  2014-12-10       Impact factor: 5.103

9.  NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.

Authors:  Alexander Köenig; Thomas Linhart; Katrin Schlengemann; Kristina Reutlinger; Jessica Wegele; Guido Adler; Garima Singh; Leonie Hofmann; Steffen Kunsch; Thomas Büch; Eva Schäfer; Thomas M Gress; Martin E Fernandez-Zapico; Volker Ellenrieder
Journal:  Gastroenterology       Date:  2009-11-06       Impact factor: 22.682

10.  Cyclin D1 is a bona fide target gene of NFATc1 and is sufficient in the mediation of injury-induced vascular wall remodeling.

Authors:  Manjula Karpurapu; Dong Wang; Dong Van Quyen; Tae-Kang Kim; Venkatesh Kundumani-Sridharan; Srinidhi Pulusani; Gadiparthi N Rao
Journal:  J Biol Chem       Date:  2009-11-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.